Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
Ricardo Correa, MD, EdD, the director of the University of Arizona endocrinology fellowship, told MedPage Today in 2022 that compounders are probably using the same active pharmacological part [semaglutide], but when you combine things and you add different excipients, the effectiveness if you dont measure that in a randomized controlled trial will not be the same. He added that not knowing exactly what the formulation contains makes prescribing too risky for him and the patient: Youre treating 100 patients and all of them have been doing fine with a compound medication you recommend
Accessed on 15 October 2025 Vishala, T., Pitchaiah, G., Pravadha, D., & Annapurna, A
Food and Drug Administration says the shortage of tirzepatide injection a glucagon-like peptide 1 medication used for diabetes and weight loss has been resolved
Unknown off-target effects on nerves are possible